Target intelligence / Profile preview

Glycosomal glyceraldehyde-3-phosphate dehydrogenase (GAPDH (glycosomal), or gGAPDH (sometimes specifically for the glycosomal isoform))

Target
GAPDH (glycosomal), or gGAPDH (sometimes specifically for the glycosomal isoform)
Molecular classification
Enzyme, Oxidoreductase (specifically EC 1.2.1.12), Glycosomal protein
01

Overview

Glycosomal glyceraldehyde-3-phosphate dehydrogenase is an isoenzyme of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) that is specifically localized within glycosomes—specialized peroxisome-like organelles found in trypanosomatid protozoa such as Leishmania and Trypanosoma. This enzyme catalyzes a crucial step in glycolysis: the NAD⁺-dependent oxidation and phosphorylation of glyceraldehyde 3-phosphate to 1,3-bisphosphoglycerate. The glycosomal isoenzyme possesses unique sequence features, such as peptide insertions, a carboxy-terminal glycosomal targeting signal, and an excess of positive charges, distinguishing it from its cytosolic counterpart and from human GAPDH. Glycosomal GAPDH is essential for ATP production in trypanosomatids and is under investigation as a drug target since its inhibition may selectively disrupt parasite viability without affecting human cells.

Other names
Glyceraldehyde 3-phosphate dehydrogenase (glycosomal)Glycosomal GAPDHGAPDH (glycosomal)Trypanosomatid glycosomal glyceraldehyde-3-phosphate dehydrogenase
02

Mechanism of action

Inhibitors would act by blocking glycolytic ATP production in parasites, leading to energy deprivation and death of the pathogen

03

Biological functions

Glycolysis (catalyzes conversion of glyceraldehyde-3-phosphate to 1,3-bisphosphoglycerate)Energy metabolism in glycosome (organelle-specific for trypanosomatid parasites)
04

Disease associations

Infection (notably in protozoan parasites such as Leishmania and Trypanosoma species)Potential parasitism/virulence factor in trypanosomatid parasites
05

Safety considerations

Host-parasite enzyme homology: Human and parasite GAPDH are related but have distinct sequences and compartmentalization; selectivity of inhibitors is a major concernPotential off-target toxicity if drugs are not selective for the glycosomal (parasite-specific) isoform
06

Interacting drugs

No clinically approved drugs specifically target glycosomal GAPDH, but it is under investigation as a druggable target in trypanosomatid infections (e.g., Leishmaniasis, African sleeping sickness)
07

Biomarkers

None specifically established for patient selection or therapeutic monitoring in clinical use; enzyme activity or expression in pathogens could serve as a research biomarker

Beyond the preview

Go deeper on Glycosomal glyceraldehyde-3-phosphate dehydrogenase (GAPDH (glycosomal), or gGAPDH (sometimes specifically for the glycosomal isoform)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glycosomal glyceraldehyde-3-phosphate dehydrogenase (GAPDH (glycosomal), or gGAPDH (sometimes specifically for the glycosomal isoform)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call